MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor

Journal of Molecular and Cellular Cardiology

Volumn 75, Issue , 2014, Pages 49-57

  Li, Sufang ^a   Ren, Jingyi ^a   Xu, Ning ^b   Zhang, Jing ^a   Geng, Qiang ^a   Cao, Chengfu ^a   Lee, Chongyou ^a   Song, Junxian ^a   Li, Jingjin ^a   Chen, Hong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Endothelial cells; Microparticles; MiRNAs; Thrombosis; Tissue factor; Unstable angina

Indexed keywords

MICRORNA; MICRORNA 19B; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTITHROMBIN; MIRN19 MICRORNA, HUMAN;

ADULT; ANTICOAGULATION; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; ENZYME RELEASE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMOSTASIS; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MALE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; UNSTABLE ANGINA PECTORIS; UPREGULATION; BLOOD; BLOOD CLOTTING; CASE CONTROL STUDY; DRUG EFFECTS; GENETICS; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REPRODUCIBILITY;

ANGINA, UNSTABLE; ANTITHROMBINS; BASE SEQUENCE; BLOOD COAGULATION; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; COHORT STUDIES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; REPRODUCIBILITY OF RESULTS; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922751644     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.06.017     Document Type: Article

References (41)

1. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
2. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108:1664-1672.
3. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985, 71:699-708.
4. Rittersma S.Z., van der Wal A.C., Koch K.T., Piek J.J., Henriques J.P., Mulder K.J., et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005, 111:1160-1165.
5. Davì G., Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007, 357:2482-2494.
6. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008, 359:938-949.
7. Chan M.Y., Andreotti F., Becker R.C. Hypercoagulable states in cardiovascular disease. Circulation 2008, 118:2286-2297.
8. Davie E.W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991, 30:10363-10370.
9. Edgington T.S., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991, 66:67-79.
10. Nemerson Y. Tissue factor and hemostasis. Blood 1988, 71:1-8.
11. Steffel J., Lüscher T.F., Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006, 113:722-731.
12. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013, 368:2004-2013.
13. 2 kinase phosphorylation. Circulation 2005, 111:1685-1689.
14. Napoleone E., Di Santo A., Lorenzet R. Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood 1997, 89:541-549.
15. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
16. Pillai R.S., Bhattacharyya S.N., Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol 2007, 17:118-126.
17. Zampetaki A., Mayr M. MicroRNAs in vascular and metabolic disease. Circ Res 2012, 110:508-522.
18. Latronico M.V., Catalucci D., Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res 2007, 101:1225-1236.
19. Ai J., Zhang R., Li Y., Pu J., Lu Y., Jiao J., et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010, 391:73-77.
20. D'Alessandra Y., Devanna P., Limana F., Straino S., Di Carlo A., Brambilla P.G., et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010, 31:2765-2773.
21. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107:677-684.
22. Rautou P.E., Vion A.C., Amabile N., Chironi G., Simon A., Tedgui A., et al. Microparticles, vascular function, and atherothrombosis. Circ Res 2011, 109:593-606.
23. Creemers E.E., Tijsen A.J., Pinto Y.M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res 2012, 110:483-495.
24. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., et al. Platelets amplify inflammation in arthritis collagen-dependent microparticle production. Science 2010, 327:580-583.
25. Diehl P., Fricke A., Sander L., Stamm J., Bassler N., Htun N., et al. Microparticles: major transport vehicles for distinct miRNAs in circulation. Cardiovasc Res 2012, 93:633-644.
26. Leroyer A.S., Isobe H., Lesèche G., Castier Y., Wassef M., Mallat Z., et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007, 49:772-777.
27. Villadsen S.B., Bramsen J.B., Ostenfeld M.S., Wiklund E.D., Fristrup N., Gao S., et al. The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer 2012, 106:366-374.
28. Teruel R., Pérez-Sánchez C., Corral J., Herranz M.T., Pérez-Andreu V., Saiz E., et al. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost 2011, 9:1985-1992.
29. Patel N., Tahara S.M., Malik P., Kalra V.K. Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placenta growth factor in human pulmonary endothelial cells. Biochem J 2011, 434:473-482.
30. Chen Z., Nakajima T., Tanabe N., Hinohara K., Sakao S., Kasahara Y., et al. Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene. Hum Genet 2010, 128:443-452.
31. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey D.E., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50:e1-e157.
32. Augustine D., Ayers L.V., Lima E., Newton L., Lewandowski A.J., Davis E.F., et al. Dynamic release and clearance of circulating microparticles during cardiac stress. Circ Res 2014, 114:109-113.
33. Lin S., Li S., Chen Z., He X., Zhang Y., Xu X., et al. Formation, recognition and bioactivities of a novel G-quadruplex in the STAT3 gene. Bioorg Med Chem Lett 2011, 21:5987-5991.
34. Loyer X., Vion A.C., Tedgui A., Boulanger C.M. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014, 114:345-353.
35. Fichtlscherer S., Zeiher A.M., Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?. Arterioscler Thromb Vasc Biol 2011, 31:2383-2390.
36. Yuana Y., Bertina R.M., Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011, 105:396-408.
37. Fort A., Borel C., Migliavacca E., Antonarakis S.E., Fish R.J., Neerman-Arbez M. Regulation of fibrinogen production by microRNAs. Blood 2010, 116:2608-2615.
38. Borissoff J.I., Spronk H.M., ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011, 364:1746-1760.
39. Annex B.H., Denning S.M., Channon K.M., Sketch M.H., Stack R.S., Morrissey J.H., et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995, 91:619-622.
40. Zhang X., Yu H., Lou J.R., Zheng J., Zhu H., Popescu N.I., et al. MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem 2011, 286:1429-1435.
41. Yu G., Li H., Wang X., Wu T., Zhu J., Huang S., et al. MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasion. Mol Cell Biochem 2013, 380:239-247.